| http://www.w3.org/ns/prov#value | - The drug in question has some interesting regulatory history that could be relevant to any future litigation:The F.D.A. reviewers who initially examined Pfizer???s application for Lyrica in 2004 for diabetic nerve pain found those results unimpressive, especially in comparison to Lyrica???s side effects.
|
